Impact of COVID-19 on the Mental Health of Psychiatric Inpatients.

Q3 Medicine
Innovations in clinical neuroscience Pub Date : 2023-12-01 eCollection Date: 2023-10-01
Samara White, Tammie Lee Demler, Eileen Trigoboff, Lucy Keers, Chloe Matecki
{"title":"Impact of COVID-19 on the Mental Health of Psychiatric Inpatients.","authors":"Samara White, Tammie Lee Demler, Eileen Trigoboff, Lucy Keers, Chloe Matecki","doi":"","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>The perceptions and responses to acute states of emergency may vary for people experiencing serious mental illness (SMI). Therefore, studying the mental health toll of the COVID-19 pandemic on psychiatric inpatients can inform psychiatric care in the event of future global crises. The objective of this study was to determine if there was a difference in the incidence of mental health manifestations in an adult inpatient state psychiatric facility during the COVID-19 pandemic, compared to the immediately preceding year.</p><p><strong>Methods: </strong>Medication administration history for patients who utilized an as needed (PRN) medication for anxiety, agitation, or psychosis between March 1, 2020, and February 28, 2021, were analyzed. Secondary data on the incidence of restraints and seclusions were also examined.</p><p><strong>Results: </strong>The total number of PRN medications was higher during the pre-COVID-19 time frame than during the pandemic (8,139 vs. 7,630), but this was not statistically significant. The following assessments were statistically significant: predominance of psychosis as a psychiatric symptom during the COVID-19 time frame (557 vs. 389), and the difference in PRN medication administration times between time frames as categorized by day (3,741 vs. 2,623), evening (3,844 vs. 4,239), and night (554 vs. 768).</p><p><strong>Conclusion: </strong>During the height of the COVID-19 pandemic, the use of PRN medications for psychosis increased and the use of PRN medications for anxiety and agitation decreased among inpatients at a state psychiatric hospital. These results suggest that experiencing a worldwide pandemic in a psychiatric inpatient facility may be protective in some respects but may exacerbate symptoms of psychosis.</p>","PeriodicalId":13635,"journal":{"name":"Innovations in clinical neuroscience","volume":"20 10-12","pages":"18-22"},"PeriodicalIF":0.0000,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10773606/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Innovations in clinical neuroscience","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/10/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose: The perceptions and responses to acute states of emergency may vary for people experiencing serious mental illness (SMI). Therefore, studying the mental health toll of the COVID-19 pandemic on psychiatric inpatients can inform psychiatric care in the event of future global crises. The objective of this study was to determine if there was a difference in the incidence of mental health manifestations in an adult inpatient state psychiatric facility during the COVID-19 pandemic, compared to the immediately preceding year.

Methods: Medication administration history for patients who utilized an as needed (PRN) medication for anxiety, agitation, or psychosis between March 1, 2020, and February 28, 2021, were analyzed. Secondary data on the incidence of restraints and seclusions were also examined.

Results: The total number of PRN medications was higher during the pre-COVID-19 time frame than during the pandemic (8,139 vs. 7,630), but this was not statistically significant. The following assessments were statistically significant: predominance of psychosis as a psychiatric symptom during the COVID-19 time frame (557 vs. 389), and the difference in PRN medication administration times between time frames as categorized by day (3,741 vs. 2,623), evening (3,844 vs. 4,239), and night (554 vs. 768).

Conclusion: During the height of the COVID-19 pandemic, the use of PRN medications for psychosis increased and the use of PRN medications for anxiety and agitation decreased among inpatients at a state psychiatric hospital. These results suggest that experiencing a worldwide pandemic in a psychiatric inpatient facility may be protective in some respects but may exacerbate symptoms of psychosis.

COVID-19 对精神病住院患者心理健康的影响。
目的:对于严重精神疾病(SMI)患者来说,他们对急性紧急状态的看法和反应可能各不相同。因此,研究 COVID-19 大流行病对精神病住院患者造成的心理健康影响可以为未来全球危机中的精神病护理提供参考。本研究的目的是确定在 COVID-19 大流行期间,州立精神病院成人住院患者的精神健康表现发生率与前一年相比是否存在差异:方法: 对 2020 年 3 月 1 日至 2021 年 2 月 28 日期间因焦虑、烦躁或精神病而按需用药(PRN)的患者的用药记录进行分析。此外,还研究了有关束缚和隔离发生率的辅助数据:结果:COVID-19 前的 PRN 用药总数高于大流行期间的 PRN 用药总数(8,139 对 7,630),但没有统计学意义。以下评估结果具有统计学意义:在 COVID-19 期间,精神病作为一种精神症状占主导地位(557 对 389);按白天(3741 对 2623)、傍晚(3844 对 4239)和夜间(554 对 768)分类,不同时间段的 PRN 用药时间存在差异:结论:在 COVID-19 大流行期间,一家州立精神病院的住院病人使用治疗精神病的 PRN 药物增加,而使用治疗焦虑和躁动的 PRN 药物减少。这些结果表明,在精神病院住院患者中经历世界性大流行可能在某些方面起到保护作用,但也可能加重精神病症状。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Innovations in clinical neuroscience
Innovations in clinical neuroscience Medicine-Psychiatry and Mental Health
CiteScore
2.10
自引率
0.00%
发文量
87
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信